• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CXCL12表达和环磷酸腺苷的时空差异是1型神经纤维瘤病中视神经胶质瘤独特生长模式的基础。

Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1.

作者信息

Warrington Nicole M, Woerner B Mark, Daginakatte Girish C, Dasgupta Biplab, Perry Arie, Gutmann David H, Rubin Joshua B

机构信息

Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

出版信息

Cancer Res. 2007 Sep 15;67(18):8588-95. doi: 10.1158/0008-5472.CAN-06-2220.

DOI:10.1158/0008-5472.CAN-06-2220
PMID:17875698
Abstract

Astrocytoma (glioma) formation in neurofibromatosis type 1 (NF1) occurs preferentially along the optic pathway during the first decade of life. The molecular basis for this unique pattern of gliomagenesis is unknown. Previous studies in mouse Nf1 optic glioma models suggest that this patterning results from cooperative effects of Nf1 loss in glial cells and the action of factors derived from the surrounding Nf1+/- brain. Because CXCL12 is a stroma-derived growth factor for malignant brain tumors, we tested the hypothesis that CXCL12 functions in concert with Nf1 loss to facilitate NF1-associated glioma growth. Whereas CXCL12 promoted cell death in wild-type astrocytes, it increased Nf1-/- astrocyte survival. This increase in Nf1-/- astrocyte survival in response to CXCL12 was due to sustained suppression of intracellular cyclic AMP (cAMP) levels. Moreover, the ability of CXCL12 to suppress cAMP and increase Nf1-/- astrocyte survival was a consequence of mitogen-activated protein/extracellular signal-regulated kinase kinase-dependent inhibition of CXCL12 receptor (CXCR4) desensitization. In support of an instructive role for CXCL12 in facilitating optic glioma growth, we also show that CXCL12 expression along the optic pathway is higher in infant children and young mice and is associated with low levels of cAMP. CXCL12 expression declines in multiple brain regions with increasing age, correlating with the age-dependent decline in glioma growth in children with NF1. Collectively, these studies provide a mechanism for the unique pattern of NF1-associated glioma growth.

摘要

1型神经纤维瘤病(NF1)中的星形细胞瘤(胶质瘤)形成在生命的第一个十年中优先沿着视神经通路发生。这种独特的胶质瘤发生模式的分子基础尚不清楚。先前在小鼠Nf1视神经胶质瘤模型中的研究表明,这种模式是由神经胶质细胞中Nf1缺失的协同作用以及来自周围Nf1+/-脑的因子的作用导致的。由于CXCL12是恶性脑肿瘤的一种基质衍生生长因子,我们测试了CXCL12与Nf1缺失协同作用以促进NF1相关胶质瘤生长的假设。虽然CXCL12促进野生型星形胶质细胞的细胞死亡,但它增加了Nf1-/-星形胶质细胞的存活。Nf1-/-星形胶质细胞对CXCL12的存活增加是由于细胞内环磷酸腺苷(cAMP)水平的持续抑制。此外,CXCL12抑制cAMP并增加Nf1-/-星形胶质细胞存活的能力是丝裂原活化蛋白/细胞外信号调节激酶激酶依赖性抑制CXCL12受体(CXCR4)脱敏的结果。为了支持CXCL12在促进视神经胶质瘤生长中的指导作用,我们还表明,婴幼儿和幼鼠视神经通路中的CXCL12表达较高,并且与低水平的cAMP相关。随着年龄的增长,多个脑区的CXCL12表达下降,这与NF1儿童中胶质瘤生长的年龄依赖性下降相关。这些研究共同提供了NF1相关胶质瘤生长独特模式的机制。

相似文献

1
Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1.CXCL12表达和环磷酸腺苷的时空差异是1型神经纤维瘤病中视神经胶质瘤独特生长模式的基础。
Cancer Res. 2007 Sep 15;67(18):8588-95. doi: 10.1158/0008-5472.CAN-06-2220.
2
CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.单独的 CXCL12 不足以导致 Nf1 突变型小鼠发生神经胶质瘤。
J Neuroimmunol. 2010 Jul 27;224(1-2):108-13. doi: 10.1016/j.jneuroim.2010.05.002.
3
Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth.Akt或MEK介导的mTOR抑制可抑制Nf1视神经胶质瘤的生长。
Neuro Oncol. 2015 Jun;17(6):843-53. doi: 10.1093/neuonc/nou329. Epub 2014 Dec 21.
4
Increased c-Jun-NH2-kinase signaling in neurofibromatosis-1 heterozygous microglia drives microglia activation and promotes optic glioma proliferation.神经纤维瘤病1型杂合小胶质细胞中c-Jun氨基末端激酶信号增强驱动小胶质细胞活化并促进视神经胶质瘤增殖。
Cancer Res. 2008 Dec 15;68(24):10358-66. doi: 10.1158/0008-5472.CAN-08-2506.
5
RNA Sequencing of Tumor-Associated Microglia Reveals Ccl5 as a Stromal Chemokine Critical for Neurofibromatosis-1 Glioma Growth.肿瘤相关小胶质细胞的RNA测序揭示Ccl5是对1型神经纤维瘤病胶质瘤生长至关重要的基质趋化因子。
Neoplasia. 2015 Oct;17(10):776-88. doi: 10.1016/j.neo.2015.10.002.
6
Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.环腺苷酸抑制足以诱导神经纤维瘤病 1 型小鼠模型中的神经胶质瘤发生。
Cancer Res. 2010 Jul 15;70(14):5717-27. doi: 10.1158/0008-5472.CAN-09-3769. Epub 2010 Jun 15.
7
NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic glioma.NG2 细胞不是鼠神经纤维瘤病 1 型(Nf1)视神经胶质瘤的起源细胞。
Oncogene. 2014 Jan 16;33(3):289-99. doi: 10.1038/onc.2012.580. Epub 2013 Jan 14.
8
Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors.蛋白质组学分析揭示了1型神经纤维瘤病相关的人类和小鼠脑肿瘤中雷帕霉素哺乳动物靶点信号通路的过度激活。
Cancer Res. 2005 Apr 1;65(7):2755-60. doi: 10.1158/0008-5472.CAN-04-4058.
9
Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1.从 1 型神经纤维瘤病的小鼠模型中深入了解视神经胶质瘤导致的视力丧失。
J Neurosci Res. 2019 Jan;97(1):45-56. doi: 10.1002/jnr.24250. Epub 2018 Apr 28.
10
Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity.小鼠视神经胶质瘤需要星形胶质细胞Nf1基因失活和Nf1基因脑杂合性。
Cancer Res. 2003 Dec 15;63(24):8573-7.

引用本文的文献

1
Accounting for Biological Sex and Gender Identity in the Pathogenesis, Artistic Depictions, and Quality of Life in Neurofibromatosis Type 1.1型神经纤维瘤病发病机制、艺术描绘及生活质量中生物性别和性别认同的考量
JID Innov. 2025 Jun 25;5(5):100393. doi: 10.1016/j.xjidi.2025.100393. eCollection 2025 Sep.
2
Emerging mechanism and therapeutic potential of neurofibromatosis type 1-related nerve system tumor: Advancing insights into tumor development.1型神经纤维瘤病相关神经系统肿瘤的新机制及治疗潜力:对肿瘤发展的深入洞察
Neurooncol Adv. 2025 Feb 16;7(1):vdaf040. doi: 10.1093/noajnl/vdaf040. eCollection 2025 Jan-Dec.
3
An Overview of Optic Pathway Glioma With Neurofibromatosis Type 1: Pathogenesis, Risk Factors, and Therapeutic Strategies.
神经纤维瘤病 1 型伴视神经通路胶质瘤概述:发病机制、危险因素和治疗策略。
Invest Ophthalmol Vis Sci. 2024 Jun 3;65(6):8. doi: 10.1167/iovs.65.6.8.
4
A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered: a clinico-radiological and histomolecular characterisation.弥漫性中线胶质瘤的一种新亚型,H3 K27 和 BRAF/FGFR1 共改变:临床放射学和组织分子特征。
Acta Neuropathol. 2023 Dec 8;147(1):2. doi: 10.1007/s00401-023-02651-4.
5
Interactions between microglia and glioma in tumor microenvironment.肿瘤微环境中,小胶质细胞与胶质瘤之间的相互作用。
Front Oncol. 2023 Aug 28;13:1236268. doi: 10.3389/fonc.2023.1236268. eCollection 2023.
6
Clinical signs and genetic evaluation of patients with neurofibromatosis type 1 with and without optic pathway gliomas in a center in Turkey.土耳其一中心的 1 型神经纤维瘤病患者视神经胶质瘤有无的临床特征和基因评估。
Childs Nerv Syst. 2024 Feb;40(2):511-515. doi: 10.1007/s00381-023-06061-5. Epub 2023 Jul 4.
7
Expression of the Human Serotonin 5-HT Receptor Rescues Phenotype Profile and Restores Dysregulated Biomarkers in a Glioma Model.人类血清素 5-HT 受体的表达可挽救神经胶质瘤模型的表型特征并恢复失调的生物标志物。
Cells. 2022 Apr 9;11(8):1281. doi: 10.3390/cells11081281.
8
Friends with Benefits: Chemokines, Glioblastoma-Associated Microglia/Macrophages, and Tumor Microenvironment.有共同利益的朋友:趋化因子、胶质母细胞瘤相关的小胶质细胞/巨噬细胞和肿瘤微环境。
Int J Mol Sci. 2022 Feb 24;23(5):2509. doi: 10.3390/ijms23052509.
9
Brain tumors in Neurofibromatosis type 1.1型神经纤维瘤病中的脑肿瘤
Neurooncol Adv. 2019 Oct 26;1(1):vdz040. doi: 10.1093/noajnl/vdz040. eCollection 2019 May-Dec.
10
Pediatric Diffuse Midline Gliomas H3 K27M-Mutant and Non-Histone Mutant Midline High-Grade Gliomas in Neurofibromatosis Type 1 in Comparison With Non-Syndromic Children: A Single-Center Pilot Study.小儿弥漫性中线胶质瘤:H3 K27M 突变型和非组蛋白突变型中线高级别胶质瘤在 1 型神经纤维瘤病患儿与非综合征性患儿中的比较:一项单中心试点研究
Front Oncol. 2020 Jun 3;10:795. doi: 10.3389/fonc.2020.00795. eCollection 2020.